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Open access under the ElsIn order to investigate the role of myoepithelial cell and tumor microenvironment in salivary gland neo-
plasma, we have performed a study towards the effect of different extracellular matrix proteins (base-
ment membrane matrix, type I collagen and ﬁbronectin) on morphology and differentiation of benign
myoepithelial cells from pleomorphic adenoma cultured with malignant cell culture medium from squa-
mous cell carcinoma. We have also analyzed the expression of a-smooth muscle actin (a-SMA) and FGF-2
by immunoﬂuorescence and qPCR. Our immunoﬂuorescence results, supported by qPCR analysis, demon-
strated that a-SMA and FGF-2 were upregulated in the benign myoepithelial cells from pleomorphic ade-
noma in all studied conditions on ﬁbronectin substratum. However, the myoepithelial cells on ﬁbronectin
substratum did not alter their morphology under malignant conditioned medium stimulation and exhib-
ited a stellate morphology and, occasionally focal adhesions with the substratum. In summary, our data
demonstrated that the extracellular matrix exerts an important role in the morphology of the benign
myoepithelial cells by the presence of focal adhesions and also inducing increase FGF-2 and a-SMA
expression by these cells, especially in the ﬁbronectin substratum.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
The tumor microenvironment in the carcinogenesis process has
been emphasized in many studies, especially in breast cancer in
which is a determinant of its behavior. It is known that normal
myoepithelial cells have an important role as a tumor suppressor,
and so a defense against cancer progression.1,2 Numerous in vitro
and in vivo studies have demonstrated that the growth, survival,
polarity, and invasive behavior of breast cancer cells can be modu-
lated by myoepithelial cells and various stromal cells.3
The myoepithelial cell, which lies on the epithelial side of the
basement membrane, is thought to contribute to both the synthe-
sis and remodeling of the basal lamina. This anatomical relation-
ship suggests that myoepithelial cells may exert important
paracrine effects on normal glandular epithelium and may regulate
the progression of ductal carcinoma in situ (DCIS) to invasive
breast cancer. Thus, one important candidate for regulating the
transition of DCIS to invasive cancer is the myoepithelial cell.2e Patologia Oral, Instituto e
cha Junqueira, 13, CEP 13045-
.
ez).
evier OA license.The tumor suppressor phenotype was identiﬁed based on the abil-
ity of myoepithelial cells to inhibit the growth and invasion of
breast cancer cells in coculture assays in vitro and inhibit tumor
growth by secretion of extracellular matrix proteins, protease
inhibitors, and various growth factors.1,4
In a previous study of salivary gland, we have identiﬁed that
some myoepithelial markers (CK14, a-smooth muscle actin, calpo-
nin, P63, CD10, and D2–40) as well as laminin and maspin, were
stronger expressed in benign myoepithelial cells surrounding the
malignant epithelial cells in carcinoma ex-pleomorphic adenoma
(CXPA) in situ areas when compared with benign areas of pleomor-
phic adenoma (PA).5 In order to better understand this fact, we
have conceived an in vitro model attempting to simulate the cellu-
lar interactions of in situ structures of CXPA.6 The results demon-
strated that benign myoepithelial cells under the inﬂuence of
conditioned medium underwent phenotypic alteration repre-
sented by an increased FGF-2 content.
Besides the myoepithelial cell inﬂuence on malignant cells, the
extracellular matrix may also regulate cell proliferation and differ-
entiation mediating the tumorigenesis process in vivo and may en-
able tumor cells to metastasize and grow in an inappropriate site of
the body.7 Thus, considering that the extracellular matrix is an
important component of the tumor microenvironment, we have
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matrix proteins, such as basement membrane matrix (Matrigel),
type I collagen and ﬁbronectin on benign myoepithelial cells from
pleomorphic adenoma cultured with malignant cell culture med-
ium from squamous cell carcinoma analyzing the cell morphology
and the expression of a-smooth muscle actin (a-SMA) and FGF-2 .Materials and methods
Cell culture
Benign myoepithelial cells were obtained from explants of pleo-
morphic adenoma (PA) tumors provided by surgery. In order to
validate the analysis, cell culture replicates were obtained from
three different donors according to the methodology described in
our previous study.6,8 This study was conducted following the ap-
proval of the Ethical Committee of São Leopoldo Mandic Institute
and Research Center, Campinas, Brazil (Protocol # 09/0014).
The cells were cultured in Dulbecco’s modiﬁed Eagle medium
(DMEM) (Sigma, St. Louis, MO, USA) supplemented by 1% antimy-
cotic–antibiotic solution (10,000 units of penicillin, 10 mg of strep-
tomycin and 25 lg of amphotericin B per ml in 0.9% sodium
chloride; Sigma), containing 10% of donor calf serum (DCS; GIBCO,
Buffalo, NY), plated in 60-mm diameter plastic culture dishes and
incubated under standard cell culture conditions (37 C, 100%
humidity, 95% air, and 5% CO2) following the used protocol for this
cell lineage culture.8 After the cells had reached conﬂuence, they
were detached with 0.05% trypsin and subculture at a density of
110 cells/mm2 on the top of different extracellular matrix proteins.
Matrigel (BD Biosciences, California, USA) at 6 mg/ml, Human Col-
lagen Type I (BD Biosciences) at 0.3 mg/ml and Fibronectin (Sigma)
at 20 lg/ml were placed in the polystyrene plate or 13 mm cover-
slips for the following experiments. The benign myoepithelial cells
from PA were cultured in DMEM for 24 h before cultured with con-
ditioned malignant medium.
For the in vitro induction with conditioned medium, squamous
cell carcinoma cells (CAL27) obtained from American Type Culture
Collection (ATCC, Manassas, VA, USA) were used in the same den-
sity (110 cells/mm2) and medium (DMEM) described for myoepi-
thelial cells. The medium of these cells was removed 48 h after
plating and then benign myoepithelial cells from PA cultures in
DMEM for 24 h were incubated with the non-ﬁltered and ﬁltered
in 0.22 lm sterile syringe ﬁlter (Corning Inc., Germany) malignant
conditioned medium for 4 days. These two different conditions
were used because our previous study showed that in non-ﬁltered
malignant conditioned medium there are non-adherent viable
malignant epithelial cells from squamous cell carcinoma capable
of seeding in the plate where the benign myoepithelial cells are
cultured. As control, the analysis was carried out without malig-
nant conditioned medium (i.e. DMEM).Immunoﬂuorescence
Cell growth on coverslips in different substrata were ﬁxed in
methanol for 6 min at 20 C, rinsed in PBS followed by blocking
with 1% bovine albumin in phosphate buffer saline (PBS) for
30 min at room temperature. The primary polyclonal antibodies
used were FGF-2 (1:50, anti-rabbit, Sta. Cruz) and a-Smooth
Muscle Actin (1:50, anti-mouse, Dako Corp., Carpenteria, CA,
USA). Control staining reaction was performed using PBS in substi-
tution to the primary antibody. The secondary antibody used was
biotinylated anti-rabbit IgG or anti-mouse IgG (Vector Laboratories
Inc, Burlingame, CA, USA). Following, ﬂuorescein–streptavidin
conjugated (Vector) was used. After washing, preparations were
mounted using Vectashield DAPI-associated (40-6-diamidino-2-phenylindole) (Vector) and observed on a Zeiss Axioskop 2
conventional ﬂuorescence microscope (Carl Zeiss MicroImaging
GmbH, Germany) equipped with 63 Plan Apochromatic 1.4NA
and 100 Plan Apochromatic 1.4NA objectives in standard
conditions (Carl Zeiss, Oberköchen, Germany). To verify the mor-
phological changes of benign myoepithelial cells from pleomorphic
adenoma cultured with malignant cell culture medium in different
substrata, the cells were also immunostained with vimentin
(1:400, anti-mouse, Dako). The immunoﬂuorescence experiments
were repeated three times for each benign myoepithelial cell
donor.
Transmission electron microscopy (TEM)
For further investigation of the myoepithelial cell interactions
with the studied substrata, after 4 days of culture in DMEM med-
ium, the main morphological aspects were analyzed by TEM. The
cells were ﬁxed in 0.1% glutaraldehyde and 4% formaldehyde in
0.1 mol/l sodium cacodylate buffer (pH 7.4) for 1 h at room tem-
perature. Then, the cells were post-ﬁxed with 1% osmium tetroxide
for 1 h, dehydrated in a graded series of ethanol and embedded in
Spurr resine. Representative areas were selected for 80-nm-thick
ultrathin sections by using a Leica (Leica Instruments GmbH, Nuss-
loch, Germany) Ultracut R ultramicrotome with diamond knife and
examined with a JEM 1010 electron microscope (Jeol USA Inc., Pea-
body, MA) operating at 80 kV.
Real Time quantitative (q) PCR
Total RNA was isolated from myoepithelial cells from PA cul-
tured in different substrata using TRIzol Reagent (Invitrogen, Carls-
bad, CA, USA), submitted to electrophoresis on 1.2% agarose/6%
formaldehyde gels to check quality/integrity, and quantiﬁed with
a NanoVue spectrophotometer (GE Healthcare, Bjorkgatan, Swe-
den). Aliquots of 1 lg total RNA from each sample were treated
with DNase I (Invitrogen) and used for duplicate reverse transcrip-
tion reactions with the Superscript III First Strand cDNA Synthesis
kit (Invitrogen), according to the manufacturer’s instructions. The
primer sets were as follows: 50-GTGCTAACCGTTACCTGGCTAT-30
and 50-CCAATCGTTCAAAAAAGAAACAC-30 for FGF-2; 50-ATGCTCC-
CAGGGCTGTTTT-30 and 50-GCTTCGTCACCCACGTAGCT-30 for a-
SMA (a-smooth muscle actin); 50-AGGCCAACCGCGAGAAG-30 and
50-ACAGCCTGGATAGCAACGTACA-30 for ACTB (beta actin), used as
internal gene reference. Quantitative real time PCR was performed
using a 7300 Real Time PCR System (Applied Biosystems, Foster
City, CA, USA) with SYBR Green as detection dye. Cycling condi-
tions were 10 min at 95 C followed by 40 cycles of 95 C for 15 s
and 60 C for 1 min. No template and no reverse transcription con-
trols were used to test possible contaminations. Dissociation curve
analysis was performed after each completed PCR for primer spec-
iﬁcity and primer–dimer absence determinations. The quantiﬁca-
tion data were analyzed with the SDS System Software (Applied
Biosystems) and the relative expression levels were calculated
according to the Comparative Ct method, as 2DDCt. From each do-
nor, mRNA was obtained from the cell culture performed in dupli-
cate which was done in 3 different sets. The values obtained from
the donors in each experiment were merged to perform the statis-
tical analysis. Important to note is that the inter-individual varia-
tion was very low (data not show).
Statistics
Results are expressed as the mean ± standard deviation. In order
to compare the results among the different substrata and medium
conditions, the two-way analysis of variance (ANOVA) with post
hoc Tukey test was applied, with a signiﬁcance level of 0.05.
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Myoepithelial cell morphology did not alter under malignant
conditioned medium on ﬁbronectin and type I collagen substrata
To investigate whether the morphology of myoepithelial cells
was affected by the presence of different substrata under malig-
nant conditioned medium, the cells were examined by phase con-
trast microscopy and immunostained with vimentin which
highlights the morphology of these cells in immunoﬂuorescence
(Fig. 1). No morphological alteration was observed in cells cultured
in human type I collagen (Fig. 1g, h and i) or ﬁbronectin (Fig. 1j, k
and l) substrata under malignant conditioned medium stimulation.
In these substrata, the cells assumed a polyhedral and stellateFigure 1 Myoepithelial cells morphology on polystyrene (a, b, c), matrigel (d, e, f), type
myoepithelial cells from PA. The cells maintained the stellate morphology when cultur
malignant medium stimulation. A spindle-shaped morphology is observed on polysty
conditioned malignant medium. a, d, g, j: DMEM; b, e, h, k: ﬁltered malignant conditione
DAPI appear in blue. Bar: 100 lm.morphology in all studied conditions (DMEM, ﬁltered conditioned
malignant medium, and non-ﬁltered conditioned malignant med-
ium). On the other hand, the cells cultured with conditioned malig-
nant medium (ﬁltered and non-ﬁltered) in polystyrene (Fig. 1b and
c) and Matrigel (Fig. 1e and f) presented a spindle-shaped mor-
phology differently from the control condition (DMEM) (Fig. 1a
and d). The ultrastructural morphological examination revealed
cells containing well-developed rough endoplasmic reticulum
and Golgi apparatus, some of them exhibiting a peripheral layer
of myoﬁlaments (Fig. 2). These cells also displayed a notched (in-
dented) nucleus with granular chromatin. The presence of focal
adhesions was visualized in type I collagen and ﬁbronectin sub-
strata (Fig. 2c and d). No site of adhesion was visualized in polysty-
rene and matrigel substrata (Fig. 2a and b).I collagen (g, h, i) and ﬁbronectin (j, k, l) substrata. Immunostaining for vimentin in
ed in type I collagen (g, h, i) or ﬁbronectin (j, k, l) substrata independently of the
rene (b, c) and Matrigel (e, f) when the myoepithelial cells were cultured with
d medium; c, f, i, l: non-ﬁltered malignant conditioned medium. Nuclei stained with
Figure 2 Transmission electron micrographs in myoepithelial cells on polystyrene (a), matrigel (b), type I collagen (c) and ﬁbronectin (d) substrata in DMEM condition. Some
cells exhibited a peripheral layer of myoﬁlaments and also displayed a notched (indented) nucleus with granular chromatin. No site of adhesion was visualized in polystyrene
and matrigel substrata (a, b). The presence of focal adhesions (arrows) was visualized in type I collagen and ﬁbronectin substrata (c, d). Bars: a, b, c: 500 nm; d: 1 lm.
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The immunoﬂuorescence assay to a-SMA and FGF-2 proteins in
all substrata and conditions are represented in Figures 3 and 4,
respectively. Myoepithelial cell cultured on ﬁbronectin substratum
exhibited an enhanced immunoexpression of a-SMA indepen-
dently of the studied condition (DMEM, ﬁltered conditioned and
non-ﬁltered conditioned medium) (Fig. 3j, k and l). On polystyrene
(Fig. 3a, b and c), matrigel (Fig. 3d, e and f) and type I collagen
(Fig. 3g, h and i) substrata, a-SMA was heterogeneously immuno-
expressed in myoepithelial cells in all studied conditions. This
could be identiﬁed through their nuclei labeled with DAPI, without
cytoplasmic immunoreactivity for a-SMA. In addition, even under
malignant conditioned medium (ﬁltered conditioned and non-
ﬁltered conditioned medium) the myoepithelial cells exhibited
the same pattern of immunoexpression of a-SMA when compared
to the control medium condition (DMEM).
FGF-2 was immunoexpressed in the myoepithelial cell cultures
in all substrata, independently of conditioned malignant medium
stimulation (ﬁltered or non-ﬁltered), and was detected as punctu-
ate deposits throughout the cytoplasm (Fig. 4). On ﬁbronectin sub-
stratum, myoepithelial cells exhibited an increase in theexpression of FGF-2 in all studied conditions (Fig. 4j, k and l) when
compared to polystyrene substratum (Fig. 4a, b and c). Myoepithe-
lial cells cultured in conditioned malignant medium seemed to
present a stronger FGF-2 staining in polystyrene (Fig. 4b and c)
and matrigel (Fig. 4e and f) substrata when compared to the con-
trol (DMEM) (Fig. 4a and d). On the other hand, no alteration in
FGF-2 immunoexpression was observed in type I collagen
(Fig. 4g, h and i).
FGF-2 and a-SMA mRNA was upregulated in ﬁbronectin substratum
In order to quantify the results obtained by immunoﬂuores-
cence, we further assessed the potential inﬂuence of the substrata
in the expression of asmooth muscle-actin and FGF-2 in benign
myoepithelial cells induced or not with the conditioned malignant
medium by qPCR (Fig. 5a and b).
The expression of a-smooth muscle actin (a-SMA) and FGF-2
mRNA was statistically signiﬁcant upregulated in benign myoepi-
thelial cells cultured in ﬁbronectin substratum in all medium con-
ditions (DMEM, ﬁltered conditioned medium, and non-ﬁltered
conditioned medium). In addition, FGF-2 mRNA expression, in
polystyrene and matrigel, was only statistically signiﬁcant
Figure 3 Immunostaining for a-SMA in myoepithelial cells on polystyrene (a, b, c), matrigel (d, e, f), type I collagen (g, h, i) and ﬁbronectin (j, k, l) substrata. a-SMA was
heterogeneously immunoexpressed in myoepithelial cells in all studied conditions, on polystyrene (a, b, c), matrigel (d, e, f) and type I collagen (g, h, i) substrata. However, on
ﬁbronectin substratum the myoepithelial cells exhibited an enhanced immunoexpression of a-SMA independently of the studied condition (j, k, l). a, d, g, j: DMEM; b, e, h, k:
ﬁltered malignant conditioned medium; c, f, i, l: non-ﬁltered malignant conditioned medium. Nuclei stained with DAPI appear in blue. Bar: 50 lm.
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conditioned medium ﬁltered and non-ﬁltered (Fig. 5b).Discussion
The present results show the importance of the extracellular
matrix in salivary gland tumor morphology and immunopheno-
type. Fibronectin substratum regulates in vitro the immunoexpres-
sion of FGF-2 and a-SMA in myoepithelial cells when compared
with type I collagen and Matrigel. This differential role in cell orga-
nization and gene expression was suggested in fetal hepatocytes
primary culture indicating the importance of this extracellular ma-
trix during normal development.9 Moreover, cancer cells areinﬂuenced by paracrine regulators from the host microenviron-
ment. Such host regulation may be important to determine tumor
cell behavior in vivo.10,11
FGF-2 and a-SMA mRNA expression were also upregulated in
benign myoepithelial cells on ﬁbronectin substratum when com-
pared with type I collagen and Matrigel in all studied conditions.
Previously, we have shown that FGF-2 was increased in benign
myoepithelial cells under stimulation by conditioned medium ob-
tained from malignant cells on polystyrene. This fact suggests that
the myoepithelial cells may receive divergent signals or a change
in the balance among the signals may occur, with excessive release
of FGF-2, eventually favouring the growth of malignant cells.6 In
addition, FGF-2 triggers the expression of a5b1 integrin on endo-
thelium of tumors which regulates angiogenesis favoring the
Figure 4 Immunostaining FGF-2 in myoepithelial cells on polystyrene (a, b, c), matrigel (d, e, f), type I collagen (g, h, i) and ﬁbronectin (j, k, l) substrata. FGF-2 was
immunoexpressed in the myoepithelial cell cultures in all substrata, independently of conditioned malignant medium stimulation (ﬁltered or non-ﬁltered), and appeared as
punctuate deposits throughout the cytoplasm. On ﬁbronectin substratum, myoepithelial cells exhibited an increase in the expression of FGF-2 in all studied conditions (j, k, l),
on polystyrene (b, c) and matrigel (e, f) substrata cultured in conditioned malignant medium. No alteration in FGF-2 immunoexpression was observed in type I collagen (g, h,
i). a, d, g, j: DMEM; b, e, h, k: ﬁltered malignant conditioned medium; c, f, i, l: non-ﬁltered malignant conditioned medium. Nuclei stained with DAPI appear in blue. Bars: a, b,
c, d, g, h, i: 100 lm; e, f, j, k, l: 50 lm.
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prone to the invasion of malignant epithelial cells in in situ
areas.12,13 However, in line with our ﬁndings, FGF-2 overexpression
on ﬁbronectin substratum may regulate myoepithelial cell differ-
entiation which is highlighted by the increase of a-SMA
expression.
Furthermore, matrix adhered cells are more responsible to fac-
tors present in the environment which then control cell prolifera-
tion and gene expression.14 This could be observed by the
upregulation of a-SMA and FGF-2 in benign myoepithelial cells
cultured in ﬁbronectin substratum in all medium conditions. In-
deed, combined integrin aggregation and ligand occupancy pro-
motes the formation of a large complex of cytoskeletal molecules
that interact with actin cytoskeleton as well as transient coaggre-
gation of growth factor receptors.15 Thus, Fibronectin substratumincreases the expression of a-SMA and FGF-2 independently of
the inﬂuence of malignant conditioned medium.
In relation to morphology, interesting observations were found.
It is already established that myoepithelial cells in cell culture ex-
hibit a polyhedral and stellate morphology.6,8 This morphology
was maintained in myoepithelial cells cultured on polystyrene
and Matrigel substrata with no conditioned medium (DMEM). On
the other hand, on the same substrata, the benign myoepithelial
cells under the inﬂuence of conditioned medium (ﬁltered and
non-ﬁltered) underwent morphological alteration characterized
by spindle-shaped morphology which is similar to normal myoep-
ithelial cells and the benign myoepithelial cells that surrounded
the malignant epithelial cells in in situ like structures of CXPA.2
It is important to highlight that the myoepithelial cell needs to
present this differentiated morphology pattern to exert its tumor
Figure 5 Relative a-SMA (a) and FGF-2 (b) mRNA expression. On ﬁbronectin
substratum, the expression of a-SMA and FGF-2 was statistically upregulated in all
studied conditions (DMEM, ﬁltered conditioned medium, non-ﬁltered conditioned
medium). Indeed, the FGF-2 mRNA expression was up-regulated in myoepithelial
cells stimulated by malignant conditioned medium on polystyrene and matrigel
substrata (b). P: polystyrene, M: matrigel, C: type I collagen, F: ﬁbronectin. Capital
letter indicates statistical difference among the substrata. Lowercase letter
indicates statistical difference among the conditions.
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ﬁbronectin and type I collagen substrata, in all studied conditions,
did not alter their morphology exhibiting a polyhedral and stellate
morphology. Moreover, on the ultra structural morphological anal-
ysis, the myoepithelial cells have interacted with ﬁbronectin and
type I collagen substrata promoting sites of adhesion (focal con-
tacts). Therefore, in vitro, these cell-binding sites could promote
a close relationship between myoepithelial cells and substrata,
establishing a high tensile strength preventing any morphological
alteration.
Cell adhesion, signaling and morphogenesis of salivary glands
depend on the interaction between the extracellular matrix and
the integrin adhesionmolecules.15,17,18 It is worth noting that these
ﬁndings are in accordance with the literature data which indicates
that neither ﬁbronectin nor non-ﬁbrillar collagen are present in the
tumor front of invasion.19,20
In malignant invasion, the ECM exerts extraordinary control on
the behavior of cells dictating whether they will proliferate or
undergo growth arrest, migrate or remain stationary and thrive or
undergo apoptotic death. The effects of the ECM on cells are mainly
mediated by the integrins, which organize the cytoskeleton and
activate intracellular signaling pathways.21 It is known that cellular
cohesion plays a critical role not only establishing compartments
and boundaries between tissues but also providing inﬂuence in
malignant invasion.22 These ﬁndings then demonstrate that thepresence of growth factors in the malignant conditioned medium
is not sufﬁcient to alter the myoepithelial cell morphology on
ﬁbronectin and type I collagen substrata.
In conclusion, this in vitro study showed that type I collagen
and especially ﬁbronectin may modify the action of malignant
cells, inducting the increase of FGF-2 by the benign myoepithelial
cells favouring the malignant cells proliferation. In addition, ﬁbro-
nectin also holds the myoepithelial cells in the matrix avoiding any
morphologic alteration. Thus, all together probably contributes to
the tumor growth and impairs the function of myoepithelial cells
as a tumor suppressor. This issue must be taken into account when
the invasion process in in situ carcinoma both in breast as in sali-
vary gland cancer is analyzed.
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